دورية أكاديمية
Clinical immunogenicity outcomes from GENEr8-1, a phase 3 study of valoctocogene roxaparvovec, an AAV5-vectored gene therapy for hemophilia A
| العنوان: | Clinical immunogenicity outcomes from GENEr8-1, a phase 3 study of valoctocogene roxaparvovec, an AAV5-vectored gene therapy for hemophilia A |
|---|---|
| المؤلفون: | Long, Brian R., Robinson, Tara M., Day, Jonathan R.S., Yu, Hua, Lau, Kelly, Imtiaz, Urooj, Patton, Kathryn S., de Hart, Greg, Henshaw, Joshua, Agarwal, Suresh, Vettermann, Christian, Zoog, Stephen J., Gupta, Soumi |
| المصدر: | In Molecular Therapy 3 July 2024 32(7):2052-2063 |
| قاعدة البيانات: | ScienceDirect |
| تدمد: | 15250016 |
|---|---|
| DOI: | 10.1016/j.ymthe.2024.05.033 |